MDWD vs GAUZ Comparison

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.